Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) EBIT Margin (2016 - 2025)

Historic EBIT Margin for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 0.15%.

  • AtriCure's EBIT Margin rose 65400.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.11%, marking a year-over-year increase of 25300.0%. This contributed to the annual value of 8.6% for FY2024, which is 19200.0% down from last year.
  • Latest data reveals that AtriCure reported EBIT Margin of 0.15% as of Q3 2025, which was up 65400.0% from 4.55% recorded in Q2 2025.
  • AtriCure's EBIT Margin's 5-year high stood at 140.04% during Q3 2021, with a 5-year trough of 26.8% in Q1 2021.
  • For the 5-year period, AtriCure's EBIT Margin averaged around 2.52%, with its median value being 8.14% (2023).
  • In the last 5 years, AtriCure's EBIT Margin soared by 1473200bps in 2021 and then crashed by -1529200bps in 2022.
  • AtriCure's EBIT Margin (Quarter) stood at 17.08% in 2021, then skyrocketed by 72bps to 4.7% in 2022, then plummeted by -73bps to 8.14% in 2023, then plummeted by -44bps to 11.69% in 2024, then surged by 101bps to 0.15% in 2025.
  • Its EBIT Margin was 0.15% in Q3 2025, compared to 4.55% in Q2 2025 and 4.82% in Q1 2025.